NewReferencesToProblem: verschil tussen versies

Huidige versie van 9 jul 2024 om 11:24

Reason

Upon acceptance of the revision of the HCIM Problem, in release 2024 the HCIM Problem will disappear. This means that HCIMs currently referring to the HCIM Problem will have to be modified.
The HCIM Problem represented multiple concepts and these have been modelled in separate HCIMs after the revision of the HCIM Problem.

Realisation

The following HCIMs are eligable to replace the reference to the HCIM Problem:

Depending on the nature of the concept of a HCIM currently referring to Problem, replacing the reference to the HCIM Problem requires a reference to one or more of the above HCIMs.
The table below shows, for each HCIM with a current reference to the HCIM Problem, which reference(s) will replace it.

HCIM	Current reference	Replacement reference(s)	Current information model	New information model
Admission	Problem	DiagnosticInsight Reaction Symptom	full-size	full-size
AdvanceDirective	Problem	DiagnosticInsight	full-size	full-size
Alert	Problem	DiagnosticInsight HypersensitivityIntolerance ¹	full-size	full-size
CareAgreement	Problem	DiagnosticInsight	full-size	full-size
CareTeam	Problem	DiagnosticInsight Symptom	full-size	full-size
Encounter	Problem	DiagnosticInsight HypersensitivityIntolerance Reaction Symptom	full-size	full-size
EpisodeOfCare	Problem	Condition ²	full-size	full-size
FamilyHistory	Problem	DiagnosticInsight HypersensitivityIntolerance	full-size	full-size
MedicalDevice	Problem	DiagnosticInsight	full-size	full-size
MedicationAgreement	Problem	DiagnosticInsight HypersensitivityIntolerance Reaction Symptom	full-size	full-size
MultidisciplinaryTeamMeeting	Problem	DiagnosticInsight Symptom	full-size	full-size
NursingIntervention	Problem	DiagnosticInsight Symptom	full-size	full-size
NutritionAdvice	Problem	DiagnosticInsight HypersensitivityIntolerance Reaction Symptom	full-size	full-size
Procedure	Problem	DiagnosticInsight Reaction Symptom	full-size	full-size
Signaling	Problem	DiagnosticInsight	full-size	full-size
SkinDisorder	Problem	DiagnosticInsight	full-size	full-size
TreatmentObjective	Problem	DiagnosticInsight HypersensitivityIntolerance Symptom	full-size	full-size

Notes

¹ HypersensitivityIntolerance reference should only be used when it is not medication related, as that is what the HCIM SurveillanceDecision is intended for.
² An EpisodeOfCare relates to a condition that a health professional is following.

@@ Regel 18: / Regel 18: @@
 |Current reference
 |Replacement reference(s)
-|Old information model
+|style="text-align:center;" |Current information model
-|New information model
+|style="text-align:center;" |New information model
 |-style="vertical-align: top;"
 |width="20%" |[[Admission-v2.0(2024EN)| Admission]]
@@ Regel 25: / Regel 25: @@
 |width="20%" |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:Admission-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Admission-v2.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[AdvanceDirective-v4.3(2024EN)| AdvanceDirective]]
@@ Regel 31: / Regel 32: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 |style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN).png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:AdvanceDirective-v4.3Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[Alert-v4.2(2024EN)| Alert]]
@@ Regel 37: / Regel 38: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]] [[#Notes | <sup>1</sup>]]
 |style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN).png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" | [[Bestand:Alert-v4.2Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Alert-v4.2Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[CareAgreement-v1.1(2024EN)| CareAgreement]]
@@ Regel 43: / Regel 44: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 |style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:CareAgreement-v1.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareAgreement-v1.1Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[CareTeam-v1.0.1(2024EN)| CareTeam]]
@@ Regel 49: / Regel 50: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN).png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:CareTeam-v1.0.1Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[Encounter-v6.0(2024EN)| Encounter]]
@@ Regel 55: / Regel 56: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN).png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:Encounter-v6.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Encounter-v6.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[EpisodeOfCare-v1.0(2024EN)| EpisodeOfCare]]
@@ Regel 61: / Regel 62: @@
 |[[Condition-v1.0(2024EN) | Condition]] [[#Notes | <sup>2</sup>]]
 |style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN).png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:EpisodeOfCare-v1.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[FamilyHistory-v4.0(2024EN)| FamilyHistory]]
@@ Regel 67: / Regel 68: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]
 |style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:FamilyHistory-v4.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[MedicalDevice-v4.0(2024EN)| MedicalDevice]]
@@ Regel 73: / Regel 74: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 |style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicalDevice-v4.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[MedicationAgreement-v3.0(2024EN)| MedicationAgreement]]
@@ Regel 79: / Regel 80: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN).png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MedicationAgreement-v3.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[MultidisciplinaryTeamMeeting-v2.0(2024EN)| MultidisciplinaryTeamMeeting]]
@@ Regel 85: / Regel 86: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:MultidisciplinaryTeamMeeting-v2.0Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[NursingIntervention-v4.1(2024EN)| NursingIntervention]]
@@ Regel 91: / Regel 92: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN).png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NursingIntervention-v4.1Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[NutritionAdvice-v3.2.1(2024EN)| NutritionAdvice]]
@@ Regel 97: / Regel 98: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:NutritionAdvice-v3.2.1Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[Procedure-v5.4.1(2024EN)| Procedure]]
 |[[Problem-v4.7(2024EN)|Problem]]
-|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
+|[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[Reaction-v2.0(2024EN) | Reaction]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN).png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:Procedure-v5.4.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:Procedure-v5.4.1Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[Signaling-v2.0(2024EN)| Signaling]]
@@ Regel 115: / Regel 116: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]
 |style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN).png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN).png | full-size]]
-|
+|style="text-align:center;" |[[Bestand:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:SkinDisorder-v3.4Model(2024EN)_Nieuw.png | full-size]]
 |-style="vertical-align: top;"
 |[[TreatmentObjective-v3.2.1(2024EN)| TreatmentObjective]]
@@ Regel 121: / Regel 122: @@
 |[[DiagnosticInsight-v1.0(2024EN) | DiagnosticInsight]]<br>[[HypersensitivityIntolerance-v1.0(2024EN) | HypersensitivityIntolerance]]<br>[[Symptom-v1.0(2024EN) | Symptom]]
 |style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN).png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN).png | full-size]]
-|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model_Nieuw.png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model_Nieuw.png | full-size]]
+|style="text-align:center;" | [[Bestand:TreatmentObjective-v3.2.1Model(2024EN)_Nieuw.png | 150px |link=]]<br>[[Media:TreatmentObjective-v3.2.1Model(2024EN)_Nieuw.png | full-size]]
 |}

NewReferencesToProblem: verschil tussen versies

Huidige versie van 9 jul 2024 om 11:24

Reason

Realisation

Notes

Navigatiemenu

Persoonlijke instellingen

Naamruimten

Varianten

Weergaven

Meer

Zoeken

Navigatie

Zorginformatiebouwsteen

Hulpmiddelen